Editas med stock.

Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 19.25% so far this month. During the month of March, Editas Medicine Inc’s stock price has reached a high of $9.18 and a low of $7.27. Over the last year, Editas Medicine Inc has hit prices as high as $21.60 and as low as $7.48. Year to date, Editas ...Get a real-time Editas Medicine, Inc. (EDIT) stock price quote with breaking news, financials, statistics, charts and more.Editas Medicine (NASDAQ: EDIT) has extended post-market gains to rise ~9% in early trading on Tuesday after the company announced a favorable decision issued by U.S. patent officials backing the ...Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 13.39% so far this month. During the month of March, Editas Medicine Inc’s stock price has reached a high of $9.18 and a low of $7.48. Over the last year, Editas Medicine Inc has hit prices as high as $21.60 and as low as $7.71. Year to date, Editas ...Detailed statistics for Editas Medicine, Inc. (EDIT) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Editas Medicine, Inc. (EDIT) ... Editas Medicine, Inc. (EDIT) NASDAQ: EDIT · IEX Real-Time Price · USD. Add to Watchlist 7.67-0.20 (-2.54%) Nov 10, 2023, 4:00 PM EST ...

Stock Quote. Change Volume 52 Week High 52 Week Low Dec 2, 2023 5:42 PM EST. ... Editas Medicine, Inc. Phone: 617.401.0113 E-mail: [email protected] Medicine intends to grant the underwriters a 30-day option to purchase up to an additional 525,000 shares of its common stock. All of the shares in the offering are to be sold by Editas ...

On June 15, Editas Medicine ( EDIT 3.66%) saw its shares collapse by 15% after announcing it would be issuing new stock to raise approximately $125 million. The biotech will almost certainly use ...

Editas Medicine stock has received a consensus rating of hold. The average rating score is and is based on 17 buy ratings, 21 hold ratings, and 7 sell ratings. What was the 52-week low for Editas ...Biogen. Sep 2006 - Jun 2021 14 years 10 months. Cambridge, MA. • Leader in development, qualification, documentation and transfer of bioanalytical methods on various assay platforms, including ...Jun 14, 2023 · CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it intends to offer and sell $125 million of shares of its common stock in an underwritten public offering. Editas Medicine intends to grant the underwriters a 30-day option to purchase up to an ... The past month has been a great one for Editas Medicine (EDIT 0.86%), but the stock is still down about 89% from the peak it reached in 2021. Wall Street analysts who follow the biotechnology ...

Successfully navigating the dynamic landscape of stock investing requires an understanding of factors like momentum to judge a stock’s price trend. In this article, we take an in-depth look at Editas Medicine Inc (EDIT) to unravel why momentum evaluation plays a crucial role in making savvy investment choices.

Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently down 3.99% so far this month. During the month of August, Editas Medicine Inc’s stock price has reached a high of $9.52 and a low of $8.39. Over the last year, Editas Medicine Inc has hit prices as high as $19.97 and as low as $6.33. Year to date, Editas ...

CAMBRIDGE, Mass., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a conference call and webcast on Friday, November 3, 2023, at 8:00 a.m. ET to discuss results for the third quarter 2023 and to provide a corporate update.Top Performers. Earnings Gainers. Earnings Stalwarts. Safe (er) Stocks. Top Dividend Stocks. Stocks Under $10. Defensive Picks. Compare stocks to their industry peers at U.S. News Best Stocks.Shares of gene-editing company Editas Medicine ( EDIT 1.24%) rose by a healthy 11.5% over the course of January, according to data provided by S&P Global Market Intelligence. This big monthly gain ...Nov 8, 2021 · Shares of Editas Medicine ( EDIT 11.39%) were jumping 9.4% as of 12:27 p.m. EST on Monday. The gain came after the company provided its third-quarter update earlier in the day. Editas reported ... 29 sept 2021 ... Editas Medicine (EDIT) said Wednesday its CRISPR-based treatment led to meaningful improvements for one patient with a blindness-causing genetic ...

Click on the text tab and select a style of your choice. Change the size and color of the selected font to make it fit your design. You can also add some fun elements to make your 2048 x 1152 pixels YouTube channel art-pop. Select the ‘ Objects ’ bar and put in elements that fit the theme of your YouTube banner.Stifel has upgraded Editas Medicine Inc (NASDAQ: EDIT), saying the company's sickle cell disease candidate, EDIT-301's progress, has received minimal credit from investors.Shares of Editas Medicine ( EDIT 11.39%) were skyrocketing 41.5% higher as of 11:57 a.m. EST on Monday. The company didn't announce any big news over the weekend or today, so why is the stock ...Find the latest Editas Medicine, Inc. (EDIT) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Editas Medicine (EDIT 0.86%) and Bluebird Bio (BLUE 2.64%) are both beaten-down gene-editing stocks. Editas' shares are down by 65% in the last 12 months, whereas Bluebird's have fallen by 40%.Shares of clinical-stage biotech Editas Medicine ( EDIT 3.66%) rose as much as 14% on Monday, lifted by a trend over the past couple of days favoring gene-editing stocks. Editas stock also ...

Editas Medicine releases earnings for the most recent quarter on November 3. Analysts predict Editas Medicine will release losses per share of $0.575. Go here to track Editas Medicine stock price ...The Editas Medicine, Inc stock price gained 0.86% on the last trading day (Friday, 24th Nov 2023), rising from $10.49 to $10.58. During the last trading day the stock fluctuated 3.71% from a day low at $10.50 to a day high of $10.89. The price has risen in 6 of the last 10 days and is up by 34.43% over the past 2 weeks.

May-11-23 10:32AM. Editas Medicine to Present Clinical Data from the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease at the EHA 2023 Congress. (GlobeNewswire) May-10-23 06:02AM. Industry Analysts Just Upgraded Their Editas Medicine, Inc. (NASDAQ:EDIT) Revenue Forecasts By 14%. (Simply Wall St.)The Editas Medicine stock prediction results are shown below and presented as a graph, table and text information. Editas Medicine stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Editas Medicine analysts is $ 13.53. Today 200 Day Moving Average is the resistance level ...Editas Medicine has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock on the same terms and conditions. All of the shares in the offering are to be sold by Editas Medicine. The offering is expected to close on or about January 25, 2021, subject to customary closing conditions.Take Editas Medicine (EDIT 2.28%) as an example. On June 9, it reported positive phase 1/2 data from one of its programs for sickle cell disease, then on June 14 it announced a stock offering ...Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, ... Editas Medicine Inc (NASDAQ:EDIT) Real-Time Quotes. 10.68. BATS BZX Real-Time Price. As of 3:23pm ETEditas Medicine ( EDIT 0.86%) is quickly becoming one of the hottest biotech and gene therapy stocks on the market. Over the past year, it has more than doubled investors' money. Meanwhile, the ...

Editas Medicine (EDIT, $10.13) RSI Indicator left the overbought zone on November 21, 2023. Tickeron - Stocks • 5 days ago. Investors Buy High Volume of Editas Medicine Call Options (NASDAQ:EDIT) Zolmax • 6 days ago. Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information.

Dec 1, 2023 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Editas Medicine stock is Hold based on the current 1 sell rating, 6 hold ratings and 5 buy ratings for EDIT. The average twelve-month price prediction for Editas Medicine is $13.92 with a high price target of $30.00 and a low price target of $7.00. Learn ...

Company Description. Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 BRILLIANCE trial …Hillevax Inc. 12.75. +0.65. +5.37%. Get Editas Medicine Inc (EDIT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Editas Medicine, Inc. - Hold. Zacks' proprietary data indicates that Editas Medicine, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the EDIT shares relative ...12 Wall Street analysts have issued 1-year price objectives for Editas Medicine's stock. Their EDIT share price targets range from $7.00 to $30.00. On average, they expect the company's share price to reach $13.92 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price.Get the latest Editas Medicine, Inc. (EDIT) stock news and headlines to help you in your trading and investing decisions.Below is a summary of how these 5 analysts rated Editas Medicine over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the ...Discover historical prices for EDIT stock on Yahoo Finance. View daily, weekly or monthly format back to when Editas Medicine, Inc. stock was issued. Is Editas Medicine (NASDAQ:EDIT) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Last updated Tuesday October 17th 8:22pmThe Editas Medicine stock prediction results are shown below and presented as a graph, table and text information. Editas Medicine stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Editas Medicine analysts is $ 13.53. Today 200 Day Moving Average is the resistance level ...

Apr 3, 2023 · Editas Medicine (EDIT 0.86%) sits at the bleeding edge of biotech's hottest field, gene editing to treat inherited diseases. The company has shifted its focus to a product it is testing for severe ... So, the natural question for Editas Medicine (NASDAQ: ... (PTMN), a business loan provider. Below, we look at the top 10 dividend stocks listed on either the New York Stock Exchange (NYSE) or ...Oct 2, 2023 · If you've ever thought about investing in the gene-editing biotech space, Editas Medicine ( EDIT 0.71%) and CRISPR Therapeutics ( CRSP 2.34%) are doubtlessly familiar to you. While neither company ... Instagram:https://instagram. petrobras shareslegalzoom business licenseforex signal servicepcrfy stock forecast A high-level overview of Editas Medicine, Inc. (EDIT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. infosis ltdgns stock forecast Find out the direct holders, institutional holders and mutual fund holders for Editas Medicine, Inc. (EDIT). michaelburry Editas Medicine is the exclusive licensee of Harvard and Broad Institute’s Cas9 patent estates and Broad Institute’s Cas12a patent estate for human medicines.Editas Medicine (NASDAQ:EDIT), a genome-editing company, has seen a significant 20% surge in its stock, marking its largest increase over two years. This …Editas Medicine Inc Stock Price History. Editas Medicine Inc’s price is currently up 17.03% so far this month. During the month of May, Editas Medicine Inc’s stock price has reached a high of $10.71 and a low of $7.69. Over the last year, Editas Medicine Inc has hit prices as high as $19.97 and as low as $6.33. Year to date, Editas …